1. Home
  2. BLLN vs PLMR Comparison

BLLN vs PLMR Comparison

Compare BLLN & PLMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$74.61

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Logo Palomar Holdings Inc.

PLMR

Palomar Holdings Inc.

HOLD

Current Price

$120.78

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
PLMR
Founded
2016
2013
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.1B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BLLN
PLMR
Price
$74.61
$120.78
Analyst Decision
Buy
Buy
Analyst Count
7
5
Target Price
$126.71
$153.60
AVG Volume (30 Days)
380.5K
171.1K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.04
EPS
N/A
7.17
Revenue
N/A
$875,967,000.00
Revenue This Year
$46.29
$192.25
Revenue Next Year
$30.14
$19.34
P/E Ratio
N/A
$17.31
Revenue Growth
N/A
58.16
52 Week Low
$61.96
$107.75
52 Week High
$138.70
$175.85

Technical Indicators

Market Signals
Indicator
BLLN
PLMR
Relative Strength Index (RSI) 43.65 39.27
Support Level $64.99 $117.39
Resistance Level $83.20 $122.63
Average True Range (ATR) 6.30 3.47
MACD -1.22 -1.07
Stochastic Oscillator 18.08 2.33

Price Performance

Historical Comparison
BLLN
PLMR

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About PLMR Palomar Holdings Inc.

Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. It provides insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The company's Earthquake product generate high premium.

Share on Social Networks: